Skip to content
Search

Latest Stories

RPS, FIP write to world leaders to express solidarity, pharmacy's commitment to tacking climate crisis

The Royal Pharmaceutical Society (RPS) has joined the International Pharmaceutical Federation (FIP) in writing a letter to world leaders who have gathered in Glasgow to attend the COP26 summit, expressing pharmacy's commitment to tacking the climate crisis.

The letter signed by RPS and FIP officials has been sent to heads of state and national delegations. It outlines initiatives the profession can deliver as part of its contribution to the climate change crisis.


In a press release issued today (November 21) the RPS said: "Climate change is one of the greatest threats to global health in the 21st century, and the healthcare industry – being responsible for 4-5 per cent of greenhouse emissions globally – has an important role to play in battling climate change.

"Being medicines experts, pharmacists can protect the environment by continuing to support people to stay well and through reducing medicines waste, tackling air and water pollution, and implementing green pharmacy practices.

"As well as our Declaration of Climate and Ecological Emergency, we have released sustainability policies to show what pharmacy can do in relation to climate action and sustainable healthcare.

RPS president Claire Anderson said: “This is a pivotal moment in the fight against climate change and as a society we stand with FIP to champion pharmacy’s role in creating sustainable healthcare.

“With COP26 underway, this is a perfect time to inspire pharmacists to protect the environment and think about all areas that we can do better.”

More For You

Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less
Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less
GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less